By Leo Fasciocco -- TTD
Ticker Tape Digest presents its daily stock market report containing stocks to go long as Breakout Trades, Quick Trades, or Bargain Accumulation Trades.
We also feature stocks under Significant Accumulation that are poised to breakout.
Ticker Tape Digest's
Daily schedule guide for TTD subscribers
1. Pre-market - check Breakout Watch List and Quick Trades.
2. Morning - (11:30 - 12 A.M.) - check breakout stocks tape and breakout chart slide show.
3. Midday (1 P.M.) check TTD Midsession Report and see market video show.
4. After close (4 P.M.) check final TTD Report for day.
Aggressive Investors Bullish - "Breakout Stocks" - ideally suited for bull markets and special situation stocks. Potential for large returns. (See Performance)
Aggressive Investor Bullish- "Quick Trade Stocks" -ideally suited for entry into top performing issues looking for a small quick profit." (See Performance)
Conservative Investors "Bargain Buy Trades for the Long Term." Ideally suited for entry into top performing big cap stocks on pullbacks within overall up trend.(See Performance)
Aggressive Bearish Investors - "Breakdown Stocks" to Sell Short. Ideally suited for bear markets or market pull backs. Potential for large returns (See Performance)
The TTD report also contains stocks to short as breakdown plays and as bargain (swing trade) shorts.
Investors should tend to try to go with a strategy that fits with the stock market's trend, unless there is a special situation play.
TTD's Breakout Stocks - Long are most suitable for aggressive investors seeking ideal entry points into leading stocks, especially during bull markets. They can do extremely well in bull markets with gains of as much as several hundred percent.
These stocks can also do extremely well during strong market rallies, or if they are in a industry group that is performing very well. They tend to have strong earnings outlooks and are near new-52 week, or all-time highs.
TTD Quick Trade Stocks - Long These are leading issues that have pulled back in recent days, but could move higher soon. They are most suitable for Aggressive Investors willing to trade short term. These stocks will do extremely well during market advances. They have about 74% win rate. During market rally sequences the win rate is even higher. The return is small 3% to 8% in just a few days.
TTD's Bargain Buy Trades - Long - Long Term. These are for conservative bullish Investors These long-term buys are ideally suited for entry into stocks on pull backs within overall up trend. These stocks can give a good return long-term especially during a bull market.
TTD also presents Stocks To Sell or Sell Short. These issues are suitable for aggressive investors willing to take short positions both as trades or for longer-term plays. These stocks will do very well during bear markets or market pull backs.
TTD's Bearish breakdown stocks to sell short. These issues have potential to fall sharply. They often show a technical breakdown and also some fundamental business problem such as weak earnings.
TTD's multi-media updates include a slide-show that presents charts and analysis at midsession. Some times TTD presents feature analysis on stocks and the market. TTD uses Windows Media Files. (WMV).
TTD also presents a "Breakout Watch List" that is up dated daily. This list consists of key stocks in position to breakout. A close watch of this list can put you in the stock just as it breaks out. A good idea is to study the list and be ready to move into a stock quickly as it hits its breakpoint.
TTD often suggests using stop buy orders to enter. It is very important to buy a breakout stock as close as possible to the breakpoint. The idea is to get "elbow room" if the stock should follow through to the upside. This is very important in being successful in making big money with breakout stocks.
It is also essential to have a stop loss strategy for all stocks in which positions are taken. Not every stock will work as expected. It is important for investors to "police" their portfolios and avoid getting trapped in any bad positions.
Quality rating of breakout Two key factors: 1 - Stock near all-time high in price or near a 52-week high. 2 - earnings growth current year is strong. The ideal play is a stock with an Above Average Quality Rating. The stock is near a new high and will have strong earnings. TTD's other ratings are Average and Below Average.
TTD also has special feature sections on Educational Tips on Investing.
To email Mr. Leo Fasciocco firstname.lastname@example.org.
For service, email Beverly Owen email@example.com. TTD’s Tel: 1-480-926-1680.
Wednesday - February 14, 2018
TTD's Breakout Stocks
Stock Market Overview
Total Buy Breakouts so far today - 18
Quality of Breakouts - Average
Stocks Screened - 12,234
Bull side - Large list of breakouts Wednesday with some interesting plays. Aggressive investors can be venturesome.
Stock market - Daily Dow and S&P are still bearish. The Nasdaq has now turned bullish on a daily basis. The Weekly and Monthly indicators are bullish. However, one needs to be very watchful.
Stock Market Momentum
(Daily is based on a moving average)
Dow - Bearish
Dow - Bullish
Dow - Bullish,
Nasdaq - Bullish
Nasdaq - Bullish
Nasdaq - Bullish
S&P 500 - Bearish
S&P 500 - Bullish
S&P 500 - Bullish
Ticker Tape Digest's
TTD's Quality Rating of Stock - TRHC - ABOVE AVERAGE
TRHC, based in Moorestown, N.J., provides patient-specific, data-driven technology and solutions that enable healthcare firms to better serve their patients. TRHC breaks out Wednesday from a 12-week, cup-and-handle base.
TTD highlighted TRHC as a breakout out midsession video show on the Web Wednesday.
TRHC has annual revenues of $94 million.
So far today, TRHC is trading a heavy 585,594 shares, more than double its average daily volume 217,000 shares.
TRHC's 10-minute chart shows the stock clearing its breakpoint line in the morning with expanding intraday volume.
The stock worked its way to an intraday peak of $39.81 in the afternoon.
TRHC's tape action shows the recent block trades.
One can see the price for the blocks climbing from $35.84 in the prior session to as high as $39.52.
A key bullish block came in the morning when a block of 3,000 shares crossed the tape at $37.61.
That was up from the prior block at $35.84 on 4,024 shares.
TRHC products seek to optimize medication regimens to improve patient outcomes, reduce hospitalizations and manage risk.
The company delivers its solutions for medication risk management, which includes bundled prescription fulfillment and adherence packaging services for clients with complex prescriptions.
It also provides risk adjustment services, which help its clients to properly characterize a patient's acuity, or severity of health condition, and optimize the associated payments for care.
TRHC serves around 100 healthcare firms.
TRHC's 12-month performance chart shows the stock appreciating 140% versus a gain of 16% for the stock market.
TRHC's long-term chart shows the stock coming public in late 2016 at $14.05. The stock put down a base and then broke out to the upside in mid-2017. Since then the stock has surged to $38 - almost a triple.
TRHC's daily chart shows the stock climbing from $24 back in October to a peak near $36 by late November.
The stock formed a perfect cup-and-handle base.
The breakout comes with a widening of the daily spread and expansion in volume.
That is ideal.
TRHC's CCI momentum indicator is strongly bullish.
The company is expected to report 2017 earnings on March 12. The Street is predicting a 79% surge in net to 34 cents a share from the 19 cents the year before.
The stock sells with a price earnings ratio of 111. That is high but okay given the strong earnings outlook.
Net for the fourth quarter should climb 60% to 16 cents a share from 10 cents the year before.
Looking out to 2018, analysts are predicting an 84% surge in net to 62 cents a share from the anticipated 34 cents for 2017.
Profits for the first quarter of 2018 is expected to skyrocket 225% to 13 cents a share from 4 cents the year before.
The highest estimate on the Street is at 17 cents a share. So, some are looking for a big quarter.
Strategy Opinion: TTD is targeting TRHC for a move to $46 off this breakout. A protective stop can be placed near $36.
TTD rates TRHC a good intermediate-term play provided it meets earnings projections.
Suitability: Aggressive Bulls.
TTD's special research of Stock's Prior Performance:
Probability - Breakout Success - Extremely Bullish. TRHC has scored some big gains off its recent breakouts.
Probability - Earnings Response - Bullish. TRHC rose 3 times after the past 4 earnings reports when there was a significant change.
Probability: Seasonal Success - Neutral. TRHC rose an average of 3.4% in February. However, it declined an average of 4.9% in March.
Stock's Prior Performance After A Breakout
Stock's % Change from Breakout to peak - prior to cut below 50-day M/A.
Date of Breakout
Break point Price
Stocks Price Peak after Breakout - prior to cut below 50-day M/A
Date Trade Closed
(In actual trading, entry and exit points could vary depending on broker execution.
Also, ideal are breakouts to a new 52-week high or better, perhaps all-time highs.)
Stock's Long-term Chart
Stock's Performance Chart with Quarterly Earnings Markers vs. S&P 500
Insider Buying in Green - Insider Selling in Red
Stock's Monthly Seasonal Performance Chart - Past 5 Years
Showing % Months UP and % Change
|TTD's Breakout Profile Rating
Tabula Rasa Healthcare Inc. (TRHC)
|TTD Check List||Bullish||Bearish||Neutral|
|Near 52-week High||YES|
|Price Trend - Daily||YES|
|Price Trend - Long Term||YES|
|Price Daily Spread||YES|
|Base - A-D||YES|
|Prior Breakout Success||YES|
Charts of Selected Breakout Stocks
TTD's Quality Rating of Stock - IPCC - ABOVE AVERAGE
TTD's Quality Rating of Stock - RM - ABOVE AVERAGE
TTD's Quality Rating of Stock - LOGM - AVERAGE
TTD's Quality Rating of Stock - PRO - AVERAGE
Ticker Tape Digest’s Daily List of “Stocks To Sell or Sell Short” ranks stocks well timed to be sold immediately based on daily trading. The list can be used as an alert to reduce current long-term positions.
Shorts from tape action so far today - 3
Stocks Screened - 12,234
Long-Term Environment for bears: Neutral.
Bear Side - Small list of breakdown stocks Wednesday as stock market rallies broadly.
LXRX, based in the Woodlands, Tex., is a biotech firm. developing products to treat cancer and diarrhea. Annual revenues: $83 million. LXRX's stock falls sharply Wednesday cutting below key technical support. TTD sees more on the downside.
So far today, LXRX is trading 1.5 million shares, about triple its average daily volume of 585,000 shares.
The stock's decline was aided by a rating cut by JP Morgan.
LXRX fell sharply in the morning and touched a low of $8.01. The stock had a modest bounce rally back to $8.54 The stock then faded again in the afternoon.
LXRX's tape action shows the recent block trades.
One can see the price for the blocks falling from $9.29 in the prior session to as low as $8.05
A key bearish trade came in the morning when a block of 25,316 shares (duplicated) crossed the tape at $8.87.
That was down from the prior block at $9.29 on 21,371 shares late on Tuesday.
LXRX is developing treatments for human disease.
One of its products XERMELO is an orally-delivered small molecule compound approved by the FDA to treat carcinoid syndrome diarrhea.
It is developing sotagliflozin, an orally-delivered small molecule drug candidate, to treat diabetes mellitus.
This year, analysts are forecasting a loss of $1.06 a share compared with an anticipated loss of $1.39 for 2017.
The Street expects a loss of 19 cents a share for the first quarter.
LXRX's 12-month performance chart shows the stock down 42% versus a 17% gain for the stock market.
Insiders were buyers recently at $9.47 to $12.65 a share. There has been no insider selling.
LXRX's daily chart shows the stock trending lower. It tried to form a bottom around $9. However, the stock cuts below support.
Strategy Opinion: TTD is targeting LXRX for a decline to 6 within the next few months, or sooner. A protective stop buy can be placed near $8.80.
Suitability: Aggressive Bears.
TTD's special probability research of Prior Performance:
Probability - Earnings Response - Neutral. LXRX rose 5 times after the past 10 earnings reports when there was a significant change.
Probability: Seasonal Activity - Modestly Bearish. LXRX declined an average of 2.2% in February. However, it rose an average of 3.6% in March.
TTD's Quality Rating of Stock - LXRX - BELOW AVERAGE
Stock Performance Chart with Quarterly Earnings Markers vs. S&P 500
Insider Buying in Green - Insider Selling in Red
TTD columnist Leo Fasciocco has covered the stock market for over 30 years. His articles appear in many publications. He has also been a speaker at the Intershow conferences. He has been on television and radio. He is author of many educational articles about stock investing and the book “Guide To High-Performance Investing.”
For information to subscribe to the Ticker Tape Digest Services call: Beverly Owen at 1-480-926-1680.
Distributed by Corona Publishing Enterprises. TickerTape Digest Inc. 1220 W. Sherri, Gilbert, Az. 85233.
TTD “Professional Report” is available on the Web: $100 per month. Password needed. Published daily - around 20 times a month.
TTD Pro Report includes a Morning chart slide show of breakout stocks, a Midsession video-audio show with commentary on breakout stocks and shorts and a Final end of day overall report on breakout stocks for the session, short plays and accumulation plays. There are other features too such as Quick Trades and Long-term Plays.
TTD Daily Report is $39. It covers a Morning slide show of charts of stocks breaking out and a TTD end of day print report covering breakout stocks and shorts.
Credit cards accepted. Payable to Corona Publishing Enterprises.
(The information contained has been prepared from data deemed reliable but there is no guarantee of complete accuracy. Ticker Tape Digest Inc. is not affiliated with any broker, dealer or investment advisor. Nothing in this publication constitutes an offer, recommendation or solicitation to buy or sell any securities. Further research is advised. This report is copyrighted and no redistribution is permitted with out permission.)